Prevalence of anti-SARS-CoV-2 antibodies and associated factors in healthcare workers of a Mexican Covid-19 hospital

被引:1
|
作者
Herrera-Ortiz, Antonia [1 ]
Ugo Rojas-Delgado, Hector [2 ]
Garcia-Cisneros, Santa [1 ]
Xibille-Friedmann, Daniel X. [2 ]
Martinez-Barnetche, Jesus [1 ]
Olamendi-Portugal, Maria [1 ]
Minerva Gonzalez-Sanchez, Hilda [1 ,3 ]
Angel Sanchez-Aleman, Miguel [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico
[2] Hosp Gen Dr Jose G Parres, Cuernavaca, Morelos, Mexico
[3] Conacyt Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico
来源
SALUD PUBLICA DE MEXICO | 2022年 / 64卷 / 04期
关键词
SARS-CoV-2; healthcare workers; antibodies; seroprevalence; SARS-COV-2; ANTIBODIES; SEROPREVALENCE;
D O I
10.21149/13677
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To determine the prevalence of SARS-CoV-2 antibodies among healthcare workers (HCW) and to identify factors associated with infection. Materials and methods. A cross-sectional study was conducted in a Covid-19 hospital in Morelos, Mexico. Antibodies against SARS-CoV-2 spike and nucleocapsid proteins were detected by ELISA.A bivariate and multivariable Poisson regression model were performed to identify factors associated with infection. Results.Among all participants, 31% had anti-SARS-CoV-2 antibodies, while only 13.1% had reported a history of positive RT-PCR. Individuals who reported cohabiting with someone with Covid-19, and those who had a previous RT-PCR test, were more likely to be seropositive. Laboratory personnel had the lowest seroprevalence (12.0%), while social workers had the highest (35.7%). Conclusions. The results of this study show the seroprevalence of SARS-CoV-2 antibodies among HCW in a hospital in Mexico, and underline the importance of serological tests for a better estimate of prevalence in health systems where only symptomatic cases are recorded.
引用
收藏
页码:348 / 356
页数:9
相关论文
共 50 条
  • [1] Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workers
    Johannesen, Caroline Klint
    St Martin, Gry
    Lendorf, Maria Elisabeth
    Gerred, Peter
    Fyfe, Alexander
    Paton, Robert S.
    Thompson, Craig
    Molsted, Stig
    Kann, Caroline Elisabeth
    Jensen, Claus Antonio
    Hansen, Cecilie Bo
    Lokkegaard, Ellen
    Christensen, Thomas Broe
    Simons, Peter
    Fischer, Thea K.
    DANISH MEDICAL JOURNAL, 2022, 69 (05):
  • [2] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19
    Terpos, Evangelos
    Mentis, Andreas
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1695 - 1695
  • [3] A Study of Factors that Impact the Production of Anti-SARS-CoV-2 Antibodies in Patients with Covid-19
    Hussein, Nawfal R.
    Balatay, Amer
    Mohammad, Ameen M.
    Dhama, Kuldeep
    Rasheed, Narin A.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (05): : 323 - 326
  • [4] Factors associated with SARS-CoV-2 infection amongst healthcare workers in a COVID-19 designated hospital
    Al Youha, Sarah
    Alowaish, Osama
    Ibrahim, Islam K.
    Alghounaim, Mohammad
    Abu-Sheasha, Ghada A.
    Fakhra, Zainab
    Al Hendi, Sarah
    AlQabandi, Yousif
    Almazeedi, Sulaiman
    Al Asoomi, Fatima
    Al-Sabah, Salman
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (09) : 1226 - 1232
  • [5] Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
    Hiki, Makoto
    Tabe, Yoko
    Ai, Tomohiko
    Matsue, Yuya
    Harada, Norihiro
    Sugimoto, Kiichi
    Matsushita, Yasushi
    Matsushita, Masakazu
    Wakita, Mitsuru
    Misawa, Shigeki
    Idei, Mayumi
    Miida, Takashi
    Tamura, Naoto
    Takahashi, Kazuhisa
    Naito, Toshio
    PLOS ONE, 2021, 16 (04):
  • [6] Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
    Huynh, Angela
    Arnold, Donald M.
    Smith, James W.
    Moore, Jane C.
    Zhang, Ali
    Chagla, Zain
    Harvey, Bart J.
    Stacey, Hannah D.
    Ang, Jann C.
    Clare, Rumi
    Ivetic, Nikola
    Chetty, Vasudhevan T.
    Bowdish, Dawn M. E.
    Miller, Matthew S.
    Kelton, John G.
    Nazy, Ishac
    VIRUSES-BASEL, 2021, 13 (04):
  • [7] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19 REPLY
    Yang, Otto O.
    Ibarrondo, F. Javier
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1697 - 1698
  • [8] Trust of Italian healthcare professionals in COVID-19 (anti-SARS-COv-2) vaccination
    Di Valerio, Z.
    Montalti, M.
    Guaraldi, F.
    Tedesco, D.
    Nreu, B.
    Mannucci, E.
    Monami, M.
    Gori, D.
    ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA, 2022, 34 (03): : 217 - 226
  • [9] Prevalence of Anti-SARS-CoV-2 Antibodies in Poznan, Poland, after the First Wave of the COVID-19 Pandemic
    Lorent, Dagny
    Nowak, Rafal
    Roxo, Carolina
    Lenartowicz, Elzbieta
    Makarewicz, Aleksandra
    Zaremba, Bartosz
    Nowak, Szymon
    Kuszel, Lukasz
    Stefaniak, Jerzy
    Kierzek, Ryszard
    Zmora, Pawel
    VACCINES, 2021, 9 (06)
  • [10] Anti-SARS-COV-2 and self-reactive antibodies in neuropsychiatric COVID-19
    Bartley, Christopher
    Ngo, Thomas
    Dandekar, Ravi
    Song, Eric
    Alvarenga, Bonny
    Johns, Claire
    Wietstock, Sharon
    Zamecnik, Colin
    Rajan, Jayant
    Derisi, Joseph
    Spudich, Serena
    Farhadian, Shelli
    Pleasure, Samuel
    Wilson, Michael
    CHEMICAL SENSES, 2022, 47